Evaluation of the Effect of Botulinum Toxin A on the Lymphatic Endothelial Cells.
Abstract
[INTRODUCTION] Botulinum toxin A (BoTA) is a neurotoxin formed by Clostridium botulinum, with a broad medical application spectrum. While the primary effect of BoTA is on the muscles, the effects of BoTA in other systems including the blood vasculature have already been examined, revealing unexpected actions. However, no studies exist to the best of our knowledge regarding the potential effects of BoTA on the lymphatic vascular system, possessing a critical role in health and disease. Isolated human lymphatic endothelial cells (LECs) were cultured in dedicated in vitro culture systems. The analysis including imaging and cell culture approaches as well as molecular biology techniques is performed to examine the LEC alterations occurring upon exposure to different concentrations of BoTA.
[MATERIALS AND METHODS] Human LECs were cultured and expanded on collagen-coated petri dishes using endothelial basal medium and the commercial product Botox from Allergan as used for all our experiments. Harvested cells were used in various in vitro functional tests to assess the morphologic and functional properties of the BoTA-treated LECs. Gene expression analysis was performed to assess the most important lymphatic system-related genes and pathways.
[RESULTS] Concentrations of 1, 5 or 10 U of BoTA did not demonstrate a significant effect regarding the proliferation and migration capacity of the LECs versus untreated controls. Interestingly, even the smallest BoTA dose was found to significantly decrease the cord-like-structure formation capacity of the seeded LECs. Gene expression analysis was used to underpin possible molecular alterations, suggesting no significant effect of BoTA in the modification of gene expression versus the starvation medium control.
[CONCLUSION] LECs appear largely unaffected to BoTA treatment, with an isolated effect on the cord-like-structure formation capacity. Further work needs to assess the effect of BoTA on the smooth-muscle-cell-covered collecting lymphatic vessels and the possible aesthetic implications of such an effect, due to edema formation.
[LEVEL OF EVIDENCE V] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
[MATERIALS AND METHODS] Human LECs were cultured and expanded on collagen-coated petri dishes using endothelial basal medium and the commercial product Botox from Allergan as used for all our experiments. Harvested cells were used in various in vitro functional tests to assess the morphologic and functional properties of the BoTA-treated LECs. Gene expression analysis was performed to assess the most important lymphatic system-related genes and pathways.
[RESULTS] Concentrations of 1, 5 or 10 U of BoTA did not demonstrate a significant effect regarding the proliferation and migration capacity of the LECs versus untreated controls. Interestingly, even the smallest BoTA dose was found to significantly decrease the cord-like-structure formation capacity of the seeded LECs. Gene expression analysis was used to underpin possible molecular alterations, suggesting no significant effect of BoTA in the modification of gene expression versus the starvation medium control.
[CONCLUSION] LECs appear largely unaffected to BoTA treatment, with an isolated effect on the cord-like-structure formation capacity. Further work needs to assess the effect of BoTA on the smooth-muscle-cell-covered collecting lymphatic vessels and the possible aesthetic implications of such an effect, due to edema formation.
[LEVEL OF EVIDENCE V] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 시술 | botox
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | Lymphatic Endothelial Cells
|
scispacy | 1 | ||
| 해부 | LECs
→ lymphatic endothelial cells
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | endothelial basal
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 합병증 | muscles
|
scispacy | 1 | ||
| 합병증 | edema
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION] Botulinum toxin A
|
scispacy | 1 | ||
| 약물 | BoTA
→ Botulinum toxin A
|
scispacy | 1 | ||
| 약물 | neurotoxin
|
scispacy | 1 | ||
| 약물 | [CONCLUSION]
|
scispacy | 1 | ||
| 질환 | Clostridium botulinum
|
C0009055
Clostridium botulinum
|
scispacy | 1 | |
| 질환 | edema
|
C0013604
Edema
|
scispacy | 1 | |
| 질환 | LEC
|
scispacy | 1 | ||
| 질환 | cord-like-structure
|
scispacy | 1 | ||
| 기타 | Botulinum Toxin A
|
scispacy | 1 | ||
| 기타 | Clostridium botulinum
|
scispacy | 1 | ||
| 기타 | blood vasculature
|
scispacy | 1 | ||
| 기타 | lymphatic vascular
|
scispacy | 1 | ||
| 기타 | human lymphatic endothelial cells
|
scispacy | 1 | ||
| 기타 | BoTA
→ Botulinum toxin A
|
scispacy | 1 | ||
| 기타 | Human LECs
|
scispacy | 1 | ||
| 기타 | lymphatic
|
scispacy | 1 | ||
| 기타 | lymphatic vessels
|
scispacy | 1 |
MeSH Terms
Humans; Botulinum Toxins, Type A; Endothelial Cells; Cells, Cultured; Cell Proliferation; Cell Movement; Dose-Response Relationship, Drug
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.